|

Insulin icodec Clinical Trials

3 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: Awiqli

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • Novo Nordisk A/S3

Indications

  • Diabetes3
  • Diabetes Mellitus, Type 12
  • Diabetes Mellitus, Type 21

Other2 trials

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Phase 4
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Cullman, Alabama1 trial

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Cullman Clinical Trials

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.